Literature DB >> 15078961

Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis.

Iris Helfrich1, Min Chen, Rainer Schmidt, Gerhard Fürstenberger, Annette Kopp-Schneider, David Trick, Hermann-Josef Gröne, Harald Zur Hausen, Frank Rösl.   

Abstract

Papillomaviruses cause certain forms of human cancers, most notably carcinomas of the uterine cervix. In contrast to the well-established involvement of papillomavirus infection in the etiology of cervical carcinomas and in carcinomas of a rare hereditary condition, epidermodysplasia verruciformis, a causative role for cutaneous human papillomavirus types in the development of nonmelanoma skin cancer has not been proven. In order to better understand the functions of individual genes of cutaneous papillomavirus types, we generated transgenic mice carrying oncogene E6 of the Mastomys natalensis papillomavirus (MnPV), which causes keratoacanthomas of the skin in its natural host. In the present study, we demonstrate that under conditions of experimental two-stage skin carcinogenesis, fast-paced squamous cell carcinomas develop in nearly 100% of MnPV E6 transgenic mice in comparison to 10% in their nontransgenic littermates (log rank test; P < 0.0001). Therefore, we conclude that the MnPV E6 transgene favors the malignant progression of chemically induced tumors. Whereas an activating H-ras mutation is a consistent feature in benign and malignant tumors in wild-type mice, the majority of papillomas and keratoacanthomas and all squamous cell carcinomas obtained in MnPV E6 transgenic mice contain nonmutated ras alleles. These results indicate that the development of squamous cell carcinomas in MnPV E6 transgenic mice does not depend on an activated H-ras oncogene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15078961      PMCID: PMC387672          DOI: 10.1128/jvi.78.9.4797-4805.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Localization of papillomavirus and virus-specific antigens in the skin of tumor-bearing Mastomys natalensis (GRA Giessen).

Authors:  M Reinacher; H Müller; W Thiel; R L Rudolph
Journal:  Med Microbiol Immunol       Date:  1978-07-04       Impact factor: 3.402

Review 2.  Oncogene activation in chemical carcinogenesis.

Authors:  A Balmain; K Brown
Journal:  Adv Cancer Res       Date:  1988       Impact factor: 6.242

3.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

4.  Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures.

Authors:  I L Boxman; L H Mulder; F Noya; V de Waard; S Gibbs; T R Broker; F ten Kate; L T Chow; J ter Schegget
Journal:  J Invest Dermatol       Date:  2001-12       Impact factor: 8.551

Review 5.  Papillomavirus infections--a major cause of human cancers.

Authors:  H zur Hausen
Journal:  Biochim Biophys Acta       Date:  1996-10-09

6.  The regulation of myogenin gene expression during the embryonic development of the mouse.

Authors:  S P Yee; P W Rigby
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

7.  Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients.

Authors:  Thomas Meyer; Rüdiger Arndt; Ingo Nindl; Claas Ulrich; Enno Christophers; Eggert Stockfleth
Journal:  Transpl Int       Date:  2003-02-06       Impact factor: 3.782

8.  Malignant progression of papillomas induced by the initiation--promotion protocol in NMRI mouse skin.

Authors:  G Fürstenberger; A Kopp-Schneider
Journal:  Carcinogenesis       Date:  1995-01       Impact factor: 4.944

9.  Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

Authors:  C J Kemp; L A Donehower; A Bradley; A Balmain
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

10.  Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous, rasHa-activated papillomas.

Authors:  D A Greenhalgh; X J Wang; J A Rothnagel; J N Eckhardt; M I Quintanilla; J L Barber; D S Bundman; M A Longley; R Schlegel; D R Roop
Journal:  Cell Growth Differ       Date:  1994-06
View more
  7 in total

1.  Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1).

Authors:  Aayushi Uberoi; Satoshi Yoshida; Paul F Lambert
Journal:  J Virol Methods       Date:  2017-12-15       Impact factor: 2.014

2.  Skin hyperproliferation and susceptibility to chemical carcinogenesis in transgenic mice expressing E6 and E7 of human papillomavirus type 38.

Authors:  Wen Dong; Ulrich Kloz; Rosita Accardi; Sandra Caldeira; Wei-Min Tong; Zhao-Qi Wang; Lars Jansen; Matthias Dürst; Bakary S Sylla; Lutz Gissmann; Massimo Tommasino
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.

Authors:  Daniele Viarisio; Karin Mueller-Decker; Ulrich Kloz; Birgit Aengeneyndt; Annette Kopp-Schneider; Hermann-Josef Gröne; Tarik Gheit; Christa Flechtenmacher; Lutz Gissmann; Massimo Tommasino
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

Review 4.  Rodent Papillomaviruses.

Authors:  Aayushi Uberoi; Paul F Lambert
Journal:  Viruses       Date:  2017-11-27       Impact factor: 5.048

Review 5.  Mastomys Species as Model Systems for Infectious Diseases.

Authors:  Daniel Hasche; Frank Rösl
Journal:  Viruses       Date:  2019-02-21       Impact factor: 5.048

6.  Comparative Genomic Characterization of the Multimammate Mouse Mastomys coucha.

Authors:  Aaron Hardin; Kimberly A Nevonen; Walter L Eckalbar; Lucia Carbone; Nadav Ahituv
Journal:  Mol Biol Evol       Date:  2019-12-01       Impact factor: 16.240

7.  Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model.

Authors:  Sabrina E Vinzón; Ilona Braspenning-Wesch; Martin Müller; Edward K Geissler; Ingo Nindl; Hermann-Josef Gröne; Kai Schäfer; Frank Rösl
Journal:  PLoS Pathog       Date:  2014-02-20       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.